Trial Profile
Comparative phase I pharmacokinetic study of PA 8140 and PA 32540 tablets [aspirin/omeprazole]
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Apr 2014
Price :
$35
*
At a glance
- Drugs Aspirin/omeprazole (Primary)
- Indications Cardiovascular disorders; Cerebrovascular disorders; NSAID-induced ulcer
- Focus Pharmacokinetics
- Sponsors POZEN
- 02 Apr 2014 Status changed from planning to completed.
- 07 Jan 2014 New trial record